Provided by Tiger Fintech (Singapore) Pte. Ltd.

Shuttle Pharmaceuticals Inc

0.1328
-0.0137-9.35%
Post-market: 0.1300-0.0028-2.11%19:49 EDT
Volume:4.20M
Turnover:557.24K
Market Cap:1.46M
PE:-0.04
High:0.1451
Open:0.1451
Low:0.1247
Close:0.1465
Loading ...

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

TIPRANKS
·
10 hours ago

Shuttle Pharmaceuticals says reverse stock split to become effective June 16

TIPRANKS
·
Yesterday

Shuttle Pharma Announces Reverse Stock Split Will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time

THOMSON REUTERS
·
Yesterday

Shuttle Pharmaceuticals announces 25-for-1 proposed reverse stock split

TIPRANKS
·
12 Jun

Shuttle Pharmaceuticals Holdings Inc - Pharma Board Approves 25-for-1 Reverse Stock Split

THOMSON REUTERS
·
12 Jun

Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative

THOMSON REUTERS
·
12 Jun

Shuttle Pharmaceuticals appoints George Scorsis as chairman

TIPRANKS
·
05 Jun

Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors

THOMSON REUTERS
·
05 Jun

Press Release: Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors

Dow Jones
·
05 Jun

Shuttle Pharmaceuticals Holdings Inc - Implements 70% Salary Reduction for Executives - SEC Filing

THOMSON REUTERS
·
28 May

Shuttle Pharmaceuticals Implements 70% Salary Reduction for Executives, Defers CFO Compensation

Reuters
·
28 May

Shuttle Pharma Provides Corporate Update

THOMSON REUTERS
·
16 May

Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial

THOMSON REUTERS
·
09 May

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

GlobeNewswire
·
22 Apr

Shuttle Pharmaceuticals Files Provisional US Patent to Treat Prostrate Cancer

MT Newswires Live
·
11 Apr

BRIEF-Shuttle Pharmaceuticals Files Provisional Patent Application For PSMA Ligand Conjugates To Treat Prostate Cancer

Reuters
·
11 Apr

Shuttle Pharmaceuticals- Files Provisional Patent Application for Psma Ligand Conjugates to Treat Prostate Cancer

THOMSON REUTERS
·
11 Apr

Shuttle Pharmaceuticals files provisional patent application with USPTO

TIPRANKS
·
11 Apr

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer

GlobeNewswire
·
11 Apr

Shuttle Pharmaceuticals Holdings Inc - on March 21, Enters Consulting Agreement With Bowery Consulting - SEC Filing

THOMSON REUTERS
·
26 Mar